MeCP2 in central nervous system glial cells: current updates

• Autorzy: Sharma K. , Singh J. , Frost E.E. , Pillai P.
• Języki publikacji: EN

Abstrakty

EN

Methyl-CpG binding protein 2 (MeCP2) is an epigenetic regulator, which preferentially binds to methylated CpG dinucleotides in DNA. MeCP2 mutations have been linked to Rett syndrome, a neurodevelopmental disorder characterized by severe intellectual disability in females. Earlier studies indicated that loss of MeCP2 function in neuronal cells was the sole cause of Rett syndrome. Subsequent studies have linked MeCP2 expression in CNS glial cells to Rett syndrome pathogenesis. In this review, we have discussed the role of MeCP2 in glial subtypes, astrocytes, oligodendrocytes and microglia, and how loss of MeCP2 function in these cells has a profound influence on both glial and neuronal function.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2018
• Tom: 78
• Numer: 1
• Opis fizyczny: p.30-40,fig.,ref.

Twórcy

autor

Sharma K.

• Division of Neurobiology, Department of Zoology, Faculty of Science, M. S. University of Baroda, Gujarat, India

autor

Singh J.

• Division of Neurobiology, Department of Zoology, Faculty of Science, M. S. University of Baroda, Gujarat, India

autor

Frost E.E.

• Winnipeg, Manitoba, Canada

autor

Pillai P.

• Division of Neurobiology, Department of Zoology, Faculty of Science, M. S. University of Baroda, Gujarat, India

Bibliografia

• Allemang-Grand R, Ellegood J, Noakes LS, Ruston J, Justice M, Nieman BJ, Lerch JP (2017) Neuroanatomy in mouse models of Rett syndrome is related to the severity of Mecp2 mutation and behavioral phenotypes. Mol Autism 8: 32.
• Andoh-Noda T, Akamatsu W, Miyake K, Matsumoto T, Yamaguchi R, Sanosaka T, Kurosawa H (2015) Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage. Mol Brain 8: 31.
• Amir RE, Van den Veyver IB, Wan M, Tran C Q, Francke U, Zoghbi, HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185–188.
• Baker SA, Chen L, Wilkins AD, Yu P, Lichtarge O, Zoghbi, HY (2013) An AT-Hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell 152: 984–996.
• Ballas N, Grunseich C, Lu DD, Speh JC, Mandel G (2005) REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121: 645–657.
• Ballas N, Lioy D, Grunseich C, Mandel G (2009) Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 12: 311–317.
• Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiological Reviews 81: 871–927.
• Bedogni F, Rossi RL, Galli F, Cobolli Gigli C, Gandaglia A, Kilstrup-Nielsen C, Landsberger N (2014) Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action. Neurosci Biobehav Rev 46(P2): 187–201.
• Ben-Shachar S, Chahrour M, Thaller C, Shaw CA, Zoghbi HY (2009) Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet 18: 2431–2442.
• Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6–21.
• Braunschweig D, Simcox T, Samaco RC, LaSalle JM (2004) X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2−/+ mouse brain. Hum Mol Genet 13: 1275–1286.
• Chahrour M, Jung S, Shaw C, Zhou X, Wong STC, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320: 1224–1229.
• Chang Q, Khare G, Dani V, Nelson S, Jaenisch R (2006) The disease progression of Mecp2 mutant mice Is affected by the level of BDNF expression. Neuron 49: 341–348.
• Chen W, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Greenberg ME (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302: 885–889.
• Cheng P, Lin Y, Chen Y, Lee Y, Tai C (2011) Interplay between SIN3A and STAT3 mediates chromatin conformational changes and GFAP expression during cellular differentiation. PloS One 6: e22018.
• Cohen, S, Gabel HW, Hemberg M, Hutchinson AN, Sadacca LA, Ebert DH, Greenberg ME (2011) Genome-wide activity-dependent MeCP2phosphorylation regulates nervous system development and function. Neuron 72: 72–85.
• Colantuoni C, Jeon O, Hyder K (2001) Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis 8: 847–865.
• Cronk JC, Derecki NC, Ji E, Xu Y, Lampano AE, Smirnov I, Wolf Y (2015) Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli. Immunity 42: 679–691.
• Dastidar SG, Bardai FH, Ma C, Price V, Rawat V, Verma P, Mello SRD (2012) Isoform-Specific Toxicity of Mecp2 in Postmitotic Neurons: Suppression of neurotoxicity by FoxG1. J Neurosci 32: 2846–2855.
• Delépine C, Nectoux J, Letourneur F, Baud V, Chelly J, Billuart P, Bienvenu T (2015) Astrocyte transcriptome from the Mecp2308-Truncated mouse model of Rett syndrome. Neuromolecular Med 17: 353–363.
• Delépine C, Meziane H, Nectoux J, Opitz M, Smith AB, Ballatore C, Dahan M (2016) Altered microtubule dynamics and vesicular transport in mouse and human MeCP2-deficient astrocytes. Hum Mol Genet 25: 146–157.
• Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SBG, Guyenet PG, Kipnis J (2012) Wild type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484: 105–109.
• Durand T, Felice C. De, Signorini C, Oger C, Bultel-Poncé V, Guy A, Hayek J (2013) Biochimie F 2 -Dihomo-isoprostanes and brain white matter damage in stage 1 Rett syndrome. Biochimie 95: 86–90.
• Ebert D, Gabel H, Robinson N, Kastan N, Hu L, Cohen S, Greenberg M (2013) Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature 499: 341–345.
• Ezeonwuka C, Rastegar M (2014) MeCP2-related diseases and animal models. Diseases 2: 45–70.
• Ferreira AC, Pinto V, Mesquita S, Novais ADC, Sousa JC, Neves MC, Marques F (2013) Lipocalin-2 is involved in emotional behaviors and cognitive function. Front Cell Neurosci 7: 122.
• Forbes-Lorman RM, Kurian JR, Auger AP (2014) MeCP2 regulates GFAP expression within the developing brain. Brain Res 1543: 151–158.
• Forlani G, Giarda E, Ala U, Di Cunto F, Salani M, Tupler R, Landsberger N (2010) The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis. Hum Mol Genet 19: 3114–3123.
• Fulton D, Paez P, Campagnoni A (2010) The multiple roles of myelin protein genes during the development of the oligodendrocyte. ASN Neuro 2: e00027.
• Garg SK, Lioy DT, Knopp SJ, Bissonnette JM (2015) Conditional depletion of methyl-CpG-binding protein 2 in astrocytes depresses the hypercapnic ventilatory response in mice. J Appl Physiol 119: 670–676.
• Géranton SM, Morenilla-Palao C, Hunt SP (2007) A role for transcriptional repressor methyl-CpG-binding protein 2 and plasticity-related gene serum- and glucocorticoid-inducible kinase 1 in the induction of inflammatory pain states. J Neurosci 27: 6163–6173.
• Guoping F, Hutnick L (2005) Methyl-CpG binding proteins in the nervous system. Cell Res 15: 255–261.
• Hagberg B, Aicardi J, Dias K, Ramos O (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol 14: 471–479.
• Hansen JC, Ghosh RP, Woodcock CL (2010) Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin. IUBMB Life 62: 732–738.
• Harikrishnan KN, Chow MZ, Baker EK, Pal S, Bassal S, Brasacchio D, El-Osta A (2005) Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 37: 254–264.
• Heckman LD, Chahrour MH, Zoghbi HY (2014) Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice. eLife: e02676.
• Horiuchi M, Smith L, Maezawa I, Jin LW (2017) CX3CR1 ablation ameliorates motor and respiratory dysfunctions and improves survival of a Rett syndrome mouse model. Brain Behav Immun 60: 106–116.
• Hsieh J, Gage FH (2005) Chromatin remodeling in neural development and plasticity. Curr Opin Neurobiol 17: 664–671
• Itoh M, Tahimic CGT, Ide S, Otsuki A, Sasaoka T, Noguchi S, Kurimasa A (2012) Methyl CpG-binding protein isoform MeCP2_e2 is dispensable for Rett syndrome phenotypes but essential for embryo viability and placenta development. J Biol Chem 287: 13859–13867.
• Jin LW, Horiuchi M, Wulff H, Liu XB, Cortopassi GA, Erickson JD, Maezawa I (2015) Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity. J Neurosci 35: 2516–2529.
• Jung BP, Jugloff DGM, Zhang G, Logan R, Brown S, Eubanks JH (2003) The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J Neurobiol 55: 86–96.
• Kaddoum L, Panayotis N, Mazarguil H, Giglia-Mari G, Roux J, Joly E (2013) Isoform-specific anti-MeCP2 antibodies confirm that expression of the e1 isoform strongly predominates in the brain. F1000Res 2: 204.
• Khorshid AT, Zhou T, Al Taweel K, Cortes C, Lillico,R, Lakowski TM, Namaka MP (2017) Experimental autoimmune encephalomyelitis (EAE)-induced elevated expression of the E1 isoform of methyl CpG binding protein 2 (MeCP2E1): Implications in multiple sclerosis (MS)-induced neurological disability and associated myelin damage. J Int Mol Sci 18: 1254.
• Kishi N, Macklis J (2004) MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 27: 306–321.
• Klein ME, Lioy DT, Ma L, Impey S, Mandel G, Goodman RH (2007) Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci 10: 1513–1514.
• Klose R, Sarraf S, Schmiedeberg L, Mcdermott S, Stancheva I, Bird A (2005) DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol Cell 19: 667–678.
• Kokura K, Kaul SC, Wadhwa R, Nomura T, Khan MM, Shinagawa T, Ishii S (2001) The Ski protein family is required for MeCP2-mediated transcriptional repression. J Biol Chem 276: 34115–34121.
• Lagger S, Connelly JC, Schweikert G, Webb S, Selfridge J, Ramsahoye BH, Walkinshaw MD (2017) MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain. PLoS Genet 13: e1006793.
• Larimore JL, Chapleau CA, Kudo S, Theibert A, Percy K, Pozzo-Miller L (2009) Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol Dis 34: 199–211.
• Leonard H, Cobb S, Downs J (2017) Clinical and biological progress over 50 years in Rett syndrome. Nat Rev Neurol 13: 37–51.
• Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69: 905–914.
• Li W, Calfa G, Larimore J, Pozzo-Miller L (2012) Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice. Proc Natl Acad Sci USA 109: 17087–17092.
• Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK, Mandel G (2011) A role for glia in the progression of Rett’s syndrome. Nature 475: 497–500.
• Liu F, Ni JJ, Huang JJ, Kou ZW, Sun FY (2015) VEGF overexpression enhances the accumulation of phospho-S292 MeCP2 in reactive astrocytes in the adult rat striatum following cerebral ischemia. Brain Res 1599: 32–43.
• Lyst MJ, Ekiert R, Ebert DH, Merusi C, Nowak J, Guy J, Bird A (2013) Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR /SMRT co-repressor. Nat Neurosci 16: 1–14.
• Maezawa I, Swanberg S (2009) Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci 29: 5051–5061.
• Maezawa I, Jin L-W (2010) Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 30: 5346–5356.
• Mahmood A, Bibat G, Zhan A-L, Izbudak I, Farage L, Horska A, Naidu S (2010) White Matter Impairment in Rett Syndrome: Diffusion Tensor Imaging Study with Clinical Correlations. Am J Neuroradiol 31: 295–299.
• Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Sun YE (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302: 890–893.
• Meehan R, Lewis JD, Bird AP (1992) Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 20: 5085–5092.
• Mellén M, Ayata P, Dewell S, Kriaucionis S, Heintz N (2012) MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151: 1417–1430.
• Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJM, Minassian BA (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 36: 339–341.
• Montague P, McCallion AS, Davies RW, Griffiths IR (2006) Myelin-associated oligodendrocytic basic protein: a family of abundant CNS myelin proteins in search of a function. Dev Neurosci 28: 479–487.
• Nan X, Ng H, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386–389.
• Nan X, Hou J, Maclean A, Nasir J, Lafuente MJ, Shu X, Bird A (2007) Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc Natl Acad Sci USA 104: 2709–2714.
• Nance E, Kambhampati SP, Smith ES, Zhang Z, Zhang F, Singh S, Kannan S (2017) Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome. J Neuroinflammation 14: 252.
• Nectoux J, Florian C (2012) Altered microtubule dynamics in Mecp2-deficient astrocytes. Journal of Neuroscience Research 90: 990–998.
• Nguyen MVC, Felice CA, Du F, Covey MV, Robinson JK, Mandel G, Ballas N (2013) Oligodendrocyte lineage cells contribute unique features to rett syndrome neuropathology. J Neurosci 33: 18764–71874.
• Nomura Y (2005) Early behavior characteristics and sleep disturbance in Rett syndrome. Brain Dev 27: S35–S42.
• Okabe Y, Takahashi T, Mitsumasu C, Kosai K, Tanaka E, Matsuishi T (2012) Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome. PloS One, 7: e35354.
• Olson CO, Zachariah RM, Ezeonwuka CD, Liyanage VRB, Rastegar M (2014) Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements. PLoS One 9: e90645.
• Pacheco NL, Heaven MR, Holt LM, Crossman DK, Boggio KJ, Shaffer SA, Olsen ML (2017) RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome. Mol Autism 8: 56.
• Parikh ZS, Tripathi A, Pillai PP (2017) Differential regulation of MeCP2 phosphorylation by laminin in oligodendrocytes. J Mol Neurosci 62: 309–317.
• Petazzi P, Akizu N, García A, Estarás C, Martínez A, Paz D, Esteller M (2014) An increase in MECP2 dosage impairs neural tube formation. Neurobil Dis 67: 49–56.
• Ramocki MB, Tavyev YJ, Peters SU (2010) The MECP2 duplication syndrome. Am J Med Genet A 152A: 1079–1088.
• Rube HT, Lee W, Hejna M, Chen H, Yasui DH, Hess JF, Gong Q (2016) Sequence features accurately predict genome-wide MeCP2 binding in vivo. Nat Commun 7: 11025.
• Sadakata T, Mizoguchi A, Sato Y, Katoh-Semba R, Fukuda M, Mikoshiba K, Furuichi T (2004) The secretory granule-associated protein CAPS2 regulates neurotrophin release and cell survival. J Neurosci 24: 43–52.
• Saywell V, Viola A, Confort-Gouny S, Le Fur Y, Villard L, Cozzone PJ (2006) Brain magnetic resonance study of Mecp2 deletion effects on anatomy and metabolism. Biochem Biophys Res Commun 340: 776–783.
• Schafer DP, Heller CT, Gunner G, Heller M, Gordon C, Hammond T, Stevens B (2016) Microglia contribute to circuit defects in Mecp2 null mice independent of microglia-specific loss of Mecp2 expression. Elife 5 pii: e15224.
• Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11: 115–124.
• Sharma K, Singh J, Pillai PP, Frost EE (2015) Involvement of MeCP2 in regulation of myelin-related gene expression in cultured rat oligodendrocytes. J Mol Neurosci 57: 176–184.
• Skene PJ, Illingworth RS, Webb S, Kerr ARW, James KD, Turner DJ, Bird AP (2010) Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell 37: 457–468.
• Slezak M, Pfrieger FW (2003) New roles for astrocytes: regulation of CNS synaptogenesis. Trends Neurosci 26: 531–535.
• Smrt RD, Pfeiffer RL, Zhao X (2011) Age-dependent expression of MeCP2 in a heterozygous mosaic mouse model. Hum Mol Genet 20: 1834–1843.
• Tao J, Hu K, Chang Q (2009) Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc Natl Acad Sci USA 106: 4882–4887.
• Tochiki KK, Cunningham J, Hunt SP, Géranton SM (2012) The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states. Mol Pain 8: 14.
• Tremblay M-È, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A (2011) The role of microglia in the healthy brain. J Neurosci 31: 16064–16069.
• Turovsky E, Karagiannis A, Abdala AP, Gourine AV (2015) Impaired CO2 sensitivity of astrocytes in a mouse model of Rett syndrome. J Physiol 593: 3159–3168.
• Urdinguio R, Lopez-Serra L, Lopez-Nieva P, Alaminos M, Diaz-Uriarte R, Fernandez A, Esteller M (2008) Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One 3: e3669.
• Vora P, Mina R, Namaka M, Frost E (2010) A novel transcriptional regulator of myelin gene expression: implications for neurodevelopmental disorders. Neuroreport 21: 917–921.
• Wang DD, Bordey A (2008) The Astrocyte Odyssey. Prog Neurobiol 86: 342–367.
• Wang J, Wegener JE, Huang TW, Sripathy S, De Jesus-Cortes H, Xu P, Starwalt R (2015) Wild-type microglia do not reverse pathology in mouse models of Rett syndrome. Nature 521: E1–4.
• Williams EC, Zhong X, Mohamed A, Li R, Liu Y, Dong Q, Chang,Q (2014) Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet 23: 2968–2980.
• Wu H, Sun YE (2006) Epigenetic regulation of stem cell differentiation. Pediatr Res 59: 21R–25R.
• Wu W, Gu W, Xu X, Shang S, Zhao Z (2012) Downregulation of CNPase in a MeCP2 deficient mouse model of Rett syndrome. Neurol Res 34: 107–113.
• Yasui DH, Xu H, Dunaway KW, Lasalle JM, Jin L, Maezawa I (2013) MeCP2 modulates gene expression pathways in astrocytes. Mol Autism 4: 3.
• Yazdani M, Deogracias R, Guy J, Poot R, Bird A, Barde Y-A (2012) Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons. Stem Cells 30: 2128–2139.
• Young JI, Hong EP, Castle JC, Crespo-Barreto J, Aaron B, Rose MF, Zoghbi HY (2005) Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA 102: 17551–17558.
• Yusufzai T, Wolffe A (2000) Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res 28: 4172–4179.
• Zachariah RM, Olson CO, Ezeonwuka C, Rastegar M (2012) Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes. PloS One 7: e49763.
• Zhao D, Mokhtari R, Pedrosa E, Birnbaum R, Zheng D, Lachman HM (2017) Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia/macrophage activation and cellular stress. Mol Autism 8: 17.
• Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L, Chen WG, Lin Y, Savner E, Griffith EC, Hu L, Steen JA, Weitz CJ, Greenberg ME (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52: 255–269.

Identyfikatory

DOI

10.21307/ane‑2018‑007